1
|
Grzywa R, Łupicka-Słowik A, Sieńczyk M. IgYs: on her majesty's secret service. Front Immunol 2023; 14:1199427. [PMID: 37377972 PMCID: PMC10291628 DOI: 10.3389/fimmu.2023.1199427] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2023] [Accepted: 05/16/2023] [Indexed: 06/29/2023] Open
Abstract
There has been an increasing interest in using Immunoglobulin Y (IgY) antibodies as an alternative to "classical" antimicrobials. Unlike traditional antibiotics, they can be utilized on a continual basis without leading to the development of resistance. The veterinary IgY antibody market is growing because of the demand for minimal antibiotic use in animal production. IgY antibodies are not as strong as antibiotics for treating infections, but they work well as preventative agents and are natural, nontoxic, and easy to produce. They can be administered orally and are well tolerated, even by young animals. Unlike antibiotics, oral IgY supplements support the microbiome that plays a vital role in maintaining overall health, including immune system function. IgY formulations can be delivered as egg yolk powder and do not require extensive purification. Lipids in IgY supplements improve antibody stability in the digestive tract. Given this, using IgY antibodies as an alternative to antimicrobials has garnered interest. In this review, we will examine their antibacterial potential.
Collapse
|
2
|
Karthikeyan M, Indhuprakash ST, Gopal G, Ambi SV, Krishnan UM, Diraviyam T. Passive immunotherapy using chicken egg yolk antibody (IgY) against diarrheagenic E. coli: A systematic review and meta-analysis. Int Immunopharmacol 2021; 102:108381. [PMID: 34810126 DOI: 10.1016/j.intimp.2021.108381] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2021] [Revised: 10/25/2021] [Accepted: 11/15/2021] [Indexed: 11/19/2022]
Abstract
BACKGROUND Animal diarrhea due to diarrheagenic Escherichia coli (E. coli) has been a major concern in the field of livestock farming leading to a severe loss of domesticated animals. This systematic review aims to analyze medical shreds of evidence available in the literature and to discover the effect of IgY in treatment and protection against E. coli diarrhea. METHODS AND RESULTS Research reports that aimed to evaluate the effect of IgY against E. coli diarrhea were searched and collected from several databases (Science Direct, Springer link, Wiley, T&F). The collected studies were screened based on the inclusion criteria. 19 studies were identified and included in the meta-analysis. The pooled relative risk ratios were calculated for the studies and found to be statistically significant to support the therapeutic effect of IgY against E. coli diarrhea but the 95% confidence interval of a majority of studies includes a relative risk of 1. This variability between the effect of IgY in the overall estimate and individual studies accounts due to the presence of methodological heterogeneity. In addition, subgroup analysis revealed the grounds for heterogeneity. CONCLUSIONS This systematic review and meta-analysis provide concrete evidence for the favorable effect of IgY as a prophylactic and therapeutic modality against E. coli diarrhea. Yet, more research pieces of evidence with standardized animal studies aimed to utilize IgY against E. coli are vital. Further studies and trials on human subjects could open new perspectives in the application IgY as a therapeutic agent.
Collapse
Affiliation(s)
- Mukunthan Karthikeyan
- Department of Biotechnology, School of Chemical & Biotechnology, SASTRA Deemed-to-be-University, Thanjavur 613401, Tamil Nadu, India
| | - Srichandrasekar Thuthikkadu Indhuprakash
- Centre for Research in Infectious Diseases (CRID), Department of Bioengineering, School of Chemical & Biotechnology, SASTRA Deemed-to-be-University, Thanjavur 613401, Tamil Nadu, India
| | - Gayathri Gopal
- Centre for Research in Infectious Diseases (CRID), Department of Bioengineering, School of Chemical & Biotechnology, SASTRA Deemed-to-be-University, Thanjavur 613401, Tamil Nadu, India
| | - Senthil Visaga Ambi
- Centre for Research in Infectious Diseases (CRID), Department of Bioengineering, School of Chemical & Biotechnology, SASTRA Deemed-to-be-University, Thanjavur 613401, Tamil Nadu, India
| | - Uma Maheswari Krishnan
- Centre for Nanotechnology & Advanced Biomaterials (CeNTAB), School of Chemical & Biotechnology and School of Arts, Science & Humanities, SASTRA Deemed-to-be-University, Thanjavur 613401, Tamil Nadu, India
| | - Thirumalai Diraviyam
- Centre for Research in Infectious Diseases (CRID), Department of Bioengineering, School of Chemical & Biotechnology, SASTRA Deemed-to-be-University, Thanjavur 613401, Tamil Nadu, India.
| |
Collapse
|
3
|
Viegas C, Almeida B, Monteiro A, Paciência I, Rufo JC, Carolino E, Quintal-Gomes A, Twarużek M, Kosicki R, Marchand G, Aranha Caetano L, Viegas S. Settled dust assessment in clinical environment: useful for the evaluation of a wider bioburden spectrum. INTERNATIONAL JOURNAL OF ENVIRONMENTAL HEALTH RESEARCH 2021; 31:160-178. [PMID: 31240954 DOI: 10.1080/09603123.2019.1634799] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/18/2019] [Accepted: 06/18/2019] [Indexed: 06/09/2023]
Abstract
The collection and analysis of settled dust samples from indoor environments has become one of several environmental sampling methods used to assess bioburden indoors. The aim of the study was to characterize the bioburden in vacuumed settled dust from 10 Primary Health Care Centers by culture based and molecular methods. Results for bacterial load ranged from 1 to 12 CFU.g-1 of dust and Gram-negative bacteria ranged between 1 to 344 CFU.g-1 of dust. Fungal load ranged from 0 CFU.g-1 of dust to uncountable. Aspergillus section Fumigati was detected in 4 sampling sites where culture base-methods could not identify this section. Mucorales (Rhizopus sp.) was observed on 1 mg/L voriconazole. Three out of 10 settled dust samples were contaminated by mycotoxins. Settled dust sampling coupled with air sampling in a routine way might provide useful information about bioburden exposure.
Collapse
Affiliation(s)
- Carla Viegas
- H&TRC- Health & Technology Research Center, ESTeSL- Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa , Lisbon, Portugal
- Centro de Investigação em Saúde Pública, Universidade NOVA de Lisboa , Lisbon, Portugal
| | - Beatriz Almeida
- H&TRC- Health & Technology Research Center, ESTeSL- Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa , Lisbon, Portugal
| | - Ana Monteiro
- H&TRC- Health & Technology Research Center, ESTeSL- Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa , Lisbon, Portugal
- Escola Nacional de Saúde Pública, Universidade NOVA de Lisboa , Lisbon, Portugal
| | - Inês Paciência
- Portugal & Centro Hospitalar São João, Faculdade de Medicina da Universidade do Porto , Porto, Portugal
- Instituto de Ciência e Inovação em Engenharia Mecânica e Engenharia Industrial , Porto, Portugal
| | - João Cavaleiro Rufo
- Portugal & Centro Hospitalar São João, Faculdade de Medicina da Universidade do Porto , Porto, Portugal
- EPIUnit - Instituto de Saúde Pública, Universidade do Porto , Porto, Portugal
| | - Elisabete Carolino
- H&TRC- Health & Technology Research Center, ESTeSL- Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa , Lisbon, Portugal
| | - Anita Quintal-Gomes
- H&TRC- Health & Technology Research Center, ESTeSL- Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa , Lisbon, Portugal
- Faculty of Medicine, University of Lisbon Institute of Molecular Medicine , Lisbon, Portugal
| | - Magdalena Twarużek
- Department of Physiology and Toxicology, Kazimierz Wielki University, Faculty of Natural Sciences, Institute of Experimental Biology , Bydgoszcz, Poland
| | - Robert Kosicki
- Department of Physiology and Toxicology, Kazimierz Wielki University, Faculty of Natural Sciences, Institute of Experimental Biology , Bydgoszcz, Poland
| | - Geneviéve Marchand
- Institut de recherche Robert-Sauvé en santé et sécurité du travail , Montréal, Canada
| | - Liliana Aranha Caetano
- H&TRC- Health & Technology Research Center, ESTeSL- Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa , Lisbon, Portugal
- Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, University of Lisbon , Lisbon, Portugal
| | - Susana Viegas
- H&TRC- Health & Technology Research Center, ESTeSL- Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa , Lisbon, Portugal
- Centro de Investigação em Saúde Pública, Universidade NOVA de Lisboa , Lisbon, Portugal
| |
Collapse
|
4
|
Yang D, Mai K, Zhou Q, Zhu Y, Xing J, Luo C, Liu S, Zhou Q, Huang W, Luo J, Liu J. The protective efficacy of specific egg yolk immunoglobulin Y(IgY) against Riemerella Anatipestifer infections. Vet Microbiol 2020; 243:108642. [PMID: 32273021 DOI: 10.1016/j.vetmic.2020.108642] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2019] [Revised: 03/03/2020] [Accepted: 03/11/2020] [Indexed: 10/24/2022]
Abstract
Riemerella anatipestifer (RA) is the significant pathogen of septicemia and duck infectious serositis, diseases which can result in high mortality for ducklings. However, these diseases are difficult to treat because of the bacteria's broad resistance to multiple drugs. The purpose of this study was to produce a specific egg yolk immunoglobulin Y (IgY) targeted to RA, and to evaluate the protective efficacy of this IgY against RA infection. An RA-inactivated vaccine was produced via centrifugation and formalin treatment, using the most predominant serotype 2 wild-type strains in terms of worldwide prevalence. Anti-RA IgY was produced by immunizing Beijing Red No.1 hens with the inactivated vaccine. Enzyme-linked immunosorbent assays showed that the titer levels of anti-RA IgY antibodies increased significantly after exposure. Specific IgY isolated and purified from yolks effectively inhibited the growth of RA in the antibacterial activity assay, which revealed an 80 % reduction of bacteria populations. Animal experiments showed that duckling survival rates were able to reach up to 100 % after the ducklings were treated with 10 mg intramuscular injections of anti-RA IgY from 1 to 12 h after infection. However, the survival rates of ducklings treated with 30 mg of nonspecific IgY at 1 h after infection were 0%. Additionally, ducklings injected once with anti-RA IgY received complete protection in the first week, but the efficacy of this protection almost entirely disappeared after two weeks. The results suggested that specific anti-RA IgY has the potential to improve the degree of protection and responsiveness of ducklings to RA infections and provide them with passive immunity to RA. With further study, this is expected to become a new method for controlling RA infections.
Collapse
Affiliation(s)
- Dehong Yang
- WENS Foodstuff Group Co., Ltd. Research Institute, Xinxing, Guangdong, China
| | - Kaijie Mai
- WENS Foodstuff Group Co., Ltd. Research Institute, Xinxing, Guangdong, China
| | - Qi Zhou
- WENS Foodstuff Group Co., Ltd. Research Institute, Xinxing, Guangdong, China
| | - Yuanjun Zhu
- College of Animal Science and Technology, Jiangxi Agricultural University, Nanchang, Jiangxi, China
| | - Juanjuan Xing
- College of Animal Science and Technology, Hebei Normal University of Science and Technology, Qinhuangdao, Hebei, China
| | - Cuifen Luo
- WENS Foodstuff Group Co., Ltd. Research Institute, Xinxing, Guangdong, China
| | - Shiqi Liu
- College of Animal Science and Technology, Jiangxi Agricultural University, Nanchang, Jiangxi, China
| | - Qingfeng Zhou
- WENS Foodstuff Group Co., Ltd. Research Institute, Xinxing, Guangdong, China
| | - Wei Huang
- College of Bioscience and Bioengineering, Southwest University, Chongqing, China
| | - Junrong Luo
- College of Animal Science and Technology, Jiangxi Agricultural University, Nanchang, Jiangxi, China
| | - Junfa Liu
- WENS Foodstuff Group Co., Ltd. Research Institute, Xinxing, Guangdong, China.
| |
Collapse
|
5
|
Leiva CL, Cangelosi A, Mariconda V, Farace M, Geoghegan P, Brero L, Fernández-Miyakawa M, Chacana P. IgY-based antivenom against Bothrops alternatus: Production and neutralization efficacy. Toxicon 2019; 163:84-92. [DOI: 10.1016/j.toxicon.2019.03.020] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2018] [Revised: 03/11/2019] [Accepted: 03/20/2019] [Indexed: 10/27/2022]
|
6
|
Zhang H, Xu Y, Zhang Z, You J, Yang Y, Li X. Protective immunity of a Multivalent Vaccine Candidate against piglet diarrhea caused by enterotoxigenic Escherichia coli (ETEC) in a pig model. Vaccine 2018; 36:723-728. [DOI: 10.1016/j.vaccine.2017.12.026] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2017] [Revised: 11/27/2017] [Accepted: 12/11/2017] [Indexed: 01/05/2023]
|
7
|
Mohamed MI, Maary KSA, Dawoud TM, Mubarak AS, Hessain AM, Mohamed KF. Production and Evaluation of the Immuno-protective Efficacy of the Immunoglobulins IgY-antibodies Prepared Against Infectious Bursal Disease. INT J PHARMACOL 2016. [DOI: 10.3923/ijp.2016.749.753] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
8
|
Li X, Wang L, Zhen Y, Li S, Xu Y. Chicken egg yolk antibodies (IgY) as non-antibiotic production enhancers for use in swine production: a review. J Anim Sci Biotechnol 2015. [PMID: 26309735 DOI: 10.1186/s40104-015-0038-8.] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
In recent years, the use of in-feed antibiotics for growth and disease prevention in livestock production has been under severe scrutiny. The use and misuse of in-feed antibiotics has led to problems with drug residues in animal products and increased bacterial resistance. Chicken egg yolk antibodies (IgY) have attracted considerable attention as an alternative to antibiotics to maintain swine health and performance. Oral administration of IgY possesses many advantages over mammalian IgG such as cost-effectiveness, convenience and high yield. This review presents an overview of the potential to use IgY immunotherapy for the prevention and treatment of swine diarrhea diseases and speculates on the future of IgY technology. Included are a review of the potential applications of IgY in the control of enteric infections of either bacterial or viral origin such as enterotoxigenic Escherichia coli, Salmonella spp., rotavirus, porcine transmissible gastroenteritis virus, and porcine epidemic diarrhea virus. Some potential obstacles to the adoption of IgY technology are also discussed.
Collapse
Affiliation(s)
- Xiaoyu Li
- School of Life Science and Technology, Dalian University of Technology, Dalian, 116024 China ; Ministry of Education Center for Food Safety of Animal Origin, Dalian, 116620 China
| | - Lili Wang
- School of Life Science and Technology, Dalian University of Technology, Dalian, 116024 China ; Ministry of Education Center for Food Safety of Animal Origin, Dalian, 116620 China
| | - Yuhong Zhen
- Department of Pharmacy, Dalian Medical University, Dalian, 116044 China
| | - Shuying Li
- Dalian SEM Bio-Engineering Technology Co. Ltd, Dalian, 116620 China
| | - Yongping Xu
- School of Life Science and Technology, Dalian University of Technology, Dalian, 116024 China ; Ministry of Education Center for Food Safety of Animal Origin, Dalian, 116620 China
| |
Collapse
|
9
|
Li X, Wang L, Zhen Y, Li S, Xu Y. Chicken egg yolk antibodies (IgY) as non-antibiotic production enhancers for use in swine production: a review. J Anim Sci Biotechnol 2015; 6:40. [PMID: 26309735 PMCID: PMC4549021 DOI: 10.1186/s40104-015-0038-8] [Citation(s) in RCA: 46] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2015] [Accepted: 07/30/2015] [Indexed: 11/20/2022] Open
Abstract
In recent years, the use of in-feed antibiotics for growth and disease prevention in livestock production has been under severe scrutiny. The use and misuse of in-feed antibiotics has led to problems with drug residues in animal products and increased bacterial resistance. Chicken egg yolk antibodies (IgY) have attracted considerable attention as an alternative to antibiotics to maintain swine health and performance. Oral administration of IgY possesses many advantages over mammalian IgG such as cost-effectiveness, convenience and high yield. This review presents an overview of the potential to use IgY immunotherapy for the prevention and treatment of swine diarrhea diseases and speculates on the future of IgY technology. Included are a review of the potential applications of IgY in the control of enteric infections of either bacterial or viral origin such as enterotoxigenic Escherichia coli, Salmonella spp., rotavirus, porcine transmissible gastroenteritis virus, and porcine epidemic diarrhea virus. Some potential obstacles to the adoption of IgY technology are also discussed.
Collapse
Affiliation(s)
- Xiaoyu Li
- />School of Life Science and Technology, Dalian University of Technology, Dalian, 116024 China
- />Ministry of Education Center for Food Safety of Animal Origin, Dalian, 116620 China
| | - Lili Wang
- />School of Life Science and Technology, Dalian University of Technology, Dalian, 116024 China
- />Ministry of Education Center for Food Safety of Animal Origin, Dalian, 116620 China
| | - Yuhong Zhen
- />Department of Pharmacy, Dalian Medical University, Dalian, 116044 China
| | - Shuying Li
- />Dalian SEM Bio-Engineering Technology Co. Ltd, Dalian, 116620 China
| | - Yongping Xu
- />School of Life Science and Technology, Dalian University of Technology, Dalian, 116024 China
- />Ministry of Education Center for Food Safety of Animal Origin, Dalian, 116620 China
| |
Collapse
|